TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer.

Elizabeth S Duke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.